Provided by Tiger Trade Technology Pte. Ltd.

Loews

105.67
-0.7900-0.74%
Post-market: 105.670.00000.00%19:30 EDT
Volume:798.05K
Turnover:84.59M
Market Cap:21.60B
PE:12.95
High:107.05
Open:106.23
Low:105.62
Close:106.46
52wk High:121.01
52wk Low:97.38
Shares:204.43M
Float Shares:164.40M
Volume Ratio:0.72
T/O Rate:0.49%
Dividend:0.25
Dividend Rate:0.24%
EPS(TTM):8.16
EPS(LYR):7.97
ROE:9.31%
ROA:1.91%
PB:1.13
PE(LYR):13.25

Loading ...

M&A News: Family Behind Canada’s Loblaw (L) Grocery Chain Buys U.K. Drugstore Boots for $8.9 Billion

TIPRANKS
·
Yesterday

Is Loews (L) Undervalued On Its Recent Pullback Or Already Fairly Priced?

Simply Wall St.
·
Oct 03

AUO Unit Trims Capital by $20 Million

MT Newswires Live
·
Oct 01

Americans Get Back to Their Spending Ways. Economy Might be Speeding up Again.

Dow Jones
·
Sep 30

MAIA Biotechnology Expands Pivotal Phase 3 THIO-104 Non-Small Cell Lung Cancer Trial into Spain and Portugal

GlobeNewswire
·
Sep 23

MAIA Biotechnology Reports Pivotal Phase 3 Clinical Trial Progress in Advanced Non-Small Cell Lung Cancer

GlobeNewswire
·
Sep 22

NYSE Order Imbalance 69495.0 Shares on Sell Side

THOMSON REUTERS
·
Sep 17

MAIA Biotechnology Doses First U.S. Patient in Ongoing Phase 2 Non-Small Cell Lung Cancer Clinical Trial

GlobeNewswire
·
Sep 16

MAIA Biotechnology Announces Open Market Purchases of Company Stock by Long-Standing Board Member and CEO

GlobeNewswire
·
Sep 15

WCLC 2026 | Leads Biolabs’ Opamtistomig (LBL-024) Oral Presentation Demonstrates Robust Response and PFS Benefits in First‑Line NSCLC

GlobeNewswire
·
Sep 14

BioNTech and OncoC4 Present Updated Data Showing Gotistobart Nearly Doubled Median Overall Survival versus Standard-of-Care Chemotherapy in Previously Treated Squamous Non-Small Cell Lung Cancer Patients

GlobeNewswire
·
Sep 14

Press Release: Pyxis Oncology Appoints Thomas Civik Chief Executive Officer and Chairman of the Board

Dow Jones
·
Sep 08

Loews Declares BRL 0.22 Dividend Per Unit, Payable Sept. 8

Reuters
·
Sep 03

Why Alarming Bond Yields Might Drop Sooner than Investors Think

Dow Jones
·
Sep 03

New England Journal of Medicine Publishes Phase 1/2 Clinical Data on Revolution Medicines’ RASONQUE™ (daraxonrasib) in Metastatic Non-Small Cell Lung Cancer

GlobeNewswire
·
Sep 03

Pyxis Oncology to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Sep 01

Who is Rob Bonta? The AG at the heart of some of the biggest legal battles in business

CNN Business
·
Sep 01

Press Release: CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum

Dow Jones
·
Aug 31

Loews Corp. Stock Outperforms Competitors Despite Losses on the Day

Dow Jones
·
Aug 28

Press Release: CStone 2026 Interim Results: Accelerating Pipeline 2.0 Execution and Sustained Global Commercial Momentum

Dow Jones
·
Aug 27